Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MYL4 Antikörper (N-Term)

MYL4 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB40527 unconjugated
Produktnummer ABIN1881562
  • Target Alle MYL4 Antikörper anzeigen
    MYL4 (Myosin Light Chain 4, Alkali, Atrial, Embryonic (MYL4))
    Bindungsspezifität
    • 12
    • 7
    • 5
    • 3
    • 1
    • 1
    • 1
    AA 1-30, N-Term
    Reaktivität
    • 33
    • 11
    • 10
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 27
    • 7
    Kaninchen
    Klonalität
    • 29
    • 5
    Polyklonal
    Konjugat
    • 17
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MYL4 Antikörper ist unkonjugiert
    Applikation
    • 27
    • 17
    • 6
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB)
    Aufreinigung
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This MYL4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human MYL4.
    Klon
    RB40527
    Isotyp
    Ig Fraction
  • Applikationshinweise
    WB: 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Haltbarkeit
    6 months
  • Haase, Dobbernack, Tünnemann, Karczewski, Cardoso, Petzhold, Schlegel, Lutter, Pierschalek, Behlke, Morano: "Minigenes encoding N-terminal domains of human cardiac myosin light chain-1 improve heart function of transgenic rats." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 20, Issue 7, pp. 865-73, (2006) (PubMed).

    Arrell, Neverova, Fraser, Marbán, Van Eyk: "Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1." in: Circulation research, Vol. 89, Issue 6, pp. 480-7, (2001) (PubMed).

  • Target
    MYL4 (Myosin Light Chain 4, Alkali, Atrial, Embryonic (MYL4))
    Andere Bezeichnung
    MYL4 (MYL4 Produkte)
    Synonyme
    ALC1 antikoerper, AMLC antikoerper, GT1 antikoerper, ELC antikoerper, ELC1a antikoerper, MLC1a antikoerper, Myla antikoerper, myosin, light chain 4 antikoerper, myosin light chain 4 antikoerper, myosin, light polypeptide 4 antikoerper, Myl4 antikoerper, MYL4 antikoerper
    Hintergrund
    Myosin is a hexameric ATPase cellular motor protein. It is composed of two myosin heavy chains, two nonphosphorylatable myosin alkali light chains, and two phosphorylatable myosin regulatory light chains. This gene encodes a myosin alkali light chain that is found in embryonic muscle and adult atria. Two alternatively spliced transcript variants encoding the same protein have been found for this gene.
    Molekulargewicht
    21565
    NCBI Accession
    NP_001002841, NP_002467
    UniProt
    P12829
    Pathways
    Myometrial Relaxation and Contraction
Sie sind hier:
Kundenservice